An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone online asked whether selank can help with anxiety and rejection sensitive dysphoria — that intense, painful emotional reaction to feeling rejected that some people with ADHD experience. They described trying ashwagandha (a herbal supplement) for baseline anxiety, propranolol (a beta-blocker) for physical symptoms, and not having access to certain ADHD meds. They wanted something that works for sudden spikes of anxiety and that emotional sensitivity. Selank is a lab-made short chain of amino acids (a peptide) that was developed in Russia. It’s designed to act on the brain in several ways: calming anxiety-like behavior in animal tests, affecting levels of certain brain chemicals, and possibly improving attention and memory. In plain terms, it’s a tiny molecule meant to nudge brain systems that control stress and emotion. It’s not the same as common drugs like SSRIs or benzodiazepines; it’s an experimental peptide that’s been studied much more in animals than in people. What the available research shows is limited. Most convincing data come from animal studies and a few small human trials done in Russia. In animals, selank reduced anxiety-like behaviors and showed some effects on neurotransmitters. Human data are sparse, with reports of short-term anxiety reduction and cognitive effects, but the studies are small, often open-label (not blinded), and not widely reproduced. There’s no strong, large-scale evidence that selank reliably treats rejection sensitive dysphoria specifically. So the signal is interesting but weak: promising preliminary results, not proof. Why this might matter to someone with ADHD and acute emotional spikes is that selank is claimed to have a rapid anxiolytic (anxiety-reducing) effect and to be less sedating than traditional anti-anxiety drugs. That could, in theory, help with sudden emotional pain from perceived rejection without causing heavy drowsiness or blunt affect. For people who can’t use guanfacine/clonidine or who find propranolol unhelpful for mental symptoms, an agent that targets brain stress responses differently could be appealing. There are important caveats. Selank is not approved as a prescription medication in many countries and is mostly available through research channels or unregulated sources, which raises safety and quality concerns. Long-term effects, optimal dosing, and interactions with other medications (including stimulants and ADHD drugs) aren’t well studied. Side effects reported in limited studies are generally mild, but the data are too thin to be confident. If someone is considering it, they should consult a doctor, consider evidence-based treatments first, and be cautious about sourcing. Bottom line: Selank shows early promise for anxiety in small studies, but there isn’t solid evidence it will help with rejection sensitive dysphoria, and safety and regulation questions remain.
Source: r/Nootropics